Rationale, design, and baseline characteristics of a trial comparing aggressive lipid lowering with Atorvastatin Versus Revascularization Treatments (AVERT). [electronic resource]
- The American journal of cardiology Nov 1997
- 1130-3 p. digital
Angioplasty, Balloon, Coronary Anticholesteremic Agents--therapeutic use Atorvastatin Cholesterol, LDL--blood Coronary Disease--prevention & control Female Heptanoic Acids--therapeutic use Humans Male Middle Aged Myocardial Revascularization Pyrroles--therapeutic use Research Design Stents